Valuation: Curiosis, Inc.

Market Cap 164B 120M 107M 99.88M 91.02M 171M 11.58B 174M 1.21B 468M 5.9B 451M 442M 18.94B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 145M 107K 94.81K 88.66K 80.8K 152K 10.28M 154K 1.07M 415K 5.23M 401K 392K 16.81M EV / Sales 2026 *
9.45x
EV / Sales 2027 * 6.09x
Free-Float
85.65%
Yield 2026 *
-
Yield 2027 * -
1 day+9.37%
1 week+31.46%
Current month+9.37%
1 month+17.76%
3 months-17.54%
6 months-63.47%
Current year-56.16%
1 week 8,170
Extreme 8170
10,800
1 month 7,450
Extreme 7450
10,800
Current year 7,450
Extreme 7450
44,000
1 year 7,450
Extreme 7450
48,200
3 years 7,450
Extreme 7450
48,200
5 years 7,450
Extreme 7450
48,200
10 years 7,450
Extreme 7450
48,200
Manager TitleAgeSince
Chief Executive Officer 55 01/01/2015
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 55 01/01/2015
Director/Board Member 57 01/12/2016
Director/Board Member 56 01/12/2016
Change 5-day change 1-year change 3-year change Capi.($)
+9.37%+31.46% - - 111M
-2.39%-2.85%+24.18%+32.93% 250B
-3.73%-4.53%+0.36%-0.05% 156B
-1.18%+0.26%-8.55%+35.80% 144B
-0.90%-3.32%-54.93%-18.21% 63.26B
-1.66%-0.93%+11.30%+22.77% 49.75B
-2.21%-2.47%+21.64%+52.00% 48.58B
-0.95%+1.07%-18.77%-21.76% 47.99B
-0.13%+3.97%-2.56%+42.04% 46.22B
-2.36%+0.06%+34.63%+59.16% 43.17B
Average -0.61%+5.19%+0.81%+22.74% 84.81B
Weighted average by Cap. -2.05%+2.37%+4.10%+22.78%

Financials

2026 *2027 *
Net sales 15.4B 11.3M 10.04M 9.39M 8.55M 16.1M 1.09B 16.32M 114M 43.95M 554M 42.42M 41.5M 1.78B 23.9B 17.54M 15.57M 14.57M 13.27M 24.99M 1.69B 25.33M 176M 68.21M 860M 65.84M 64.41M 2.76B
Net income - -
Net Debt -18.4B -13.5M -11.99M -11.21M -10.22M -19.24M -1.3B -19.5M -136M -52.51M -662M -50.69M -49.59M -2.13B -18.4B -13.5M -11.99M -11.21M -10.22M -19.24M -1.3B -19.5M -136M -52.51M -662M -50.69M -49.59M -2.13B
Logo Curiosis, Inc.
Curiosis Inc is a Korea-based company principally engaged in the development and manufacture of bioresearch equipment, lab automation products, and medical devices. The Company is mainly engaged in the development and manufacture of bio research equipment for implementing lab automation based on bioengineering and automation control technologies, such as automated live-cell imaging systems. Additionally, the Company is engaged in the development and manufacture of lab automation systems including colony picking systems, digital pathology scanners, as well as automated cell concentration and separation systems. The Company is engaged in the manufacture and sales of cell counters and aesthetic medical devices as well.
Employees
-
Date Price Change Volume
01/10/26 ₩10,740.00 +9.37% 155,414
30/09/26 ₩9,820.00 +10.34% 225,636
29/09/26 ₩8,900.00 +4.34% 163,395
28/09/26 ₩8,530.00 +4.41% 160,532
23/09/26 ₩8,170.00 +2.12% 57,599
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A494120 Stock